{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:42:19Z","timestamp":1792042939975,"version":"4.4.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The 2024 ACMT Ward and Ryan Donovan Memorial Fund lecture was presented by Dr. Nora Volkow, the director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH). This article in an edited version of her keynote address during ACMT\u2019s 2024 Annual Scientific Meeting. During the course of her talk, Dr. Volkow discussed the historical factors contributing to the ongoing global opioid epidemic, examined the evidence behind different front-line and policy strategies used to battle the opioid epidemic, and highlighted the importance of recent cultural changes that support more deliberate screening for substance use disorders and pathways for initiating treatment of opioid use disorders in vulnerable populations. An urgent need exists to improve inclusion of social and structural determinants of health in implementation science addressing opioid use disorders, with better attention to special populations, including Native American Indians and Alaskan Natives, African Americans, those over 65\u00a0years of age, and teenagers.<\/jats:p>","DOI":"10.1007\/s13181-024-01041-w","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T15:05:00Z","timestamp":1731078300000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Groundbreaking Research from NIDA Addressing the Challenges of the Opioid Epidemic"],"prefix":"10.1007","volume":"21","author":[{"given":"Nora","family":"Volkow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-216X","authenticated-orcid":false,"given":"Leslie R.","family":"Dye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"1041_CR1","unstructured":"The Multiple Causes of Death. Data are produced by the Division of Vital Statistics, NCHS, CDC, US DHHS: https:\/\/wonder.cdc.gov\/mcd.html. Accessed 7 Oct 2024."},{"issue":"8","key":"1041_CR2","doi-asserted-by":"publisher","first-page":"e2327488","DOI":"10.1001\/jamanetworkopen.2023.27488","volume":"6","author":"CM Jones","year":"2023","unstructured":"Jones CM, Han B, Baldwin GT, et al. Use of medication for opioid use disorder among adults with past year opioid use disorder in the US. 2021. JAMA Network Open. 2023;6(8):e2327488.","journal-title":"JAMA Network Open"},{"issue":"4","key":"1041_CR3","doi-asserted-by":"publisher","first-page":"e227964","DOI":"10.1001\/jamanetworkopen.2022.7964","volume":"5","author":"M Jarlenski","year":"2022","unstructured":"Jarlenski M, Chen Q, Gao A. Association of duration of methadone or buprenorphine use during pregnancy with risk of nonfatal drug overdose among pregnant persons with opioid use disorder in the US. JAMA Network Open. 2022;5(4):e227964.","journal-title":"JAMA Network Open"},{"key":"1041_CR4","doi-asserted-by":"publisher","first-page":"109891","DOI":"10.1016\/j.drugalcdep.2023.109891","volume":"247","author":"B Ray","year":"2023","unstructured":"Ray B, Christian K, Bailey T, et al. Antecedents of fatal overdose in an adult cohort identified through administrative record linkage in Indiana, 2015\u20132022. Drug Alcohol Depend. 2023;247:109891. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109891.","journal-title":"Drug Alcohol Depend"},{"key":"1041_CR5","doi-asserted-by":"publisher","first-page":"102841","DOI":"10.1016\/j.drugpo.2020.102841","volume":"91","author":"A Macmadu","year":"2021","unstructured":"Macmadu A, Adams JW, Bessey SE, et al. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: a microsimulation modeling study. Int J Drug Policy. 2021;91:102841.","journal-title":"Int J Drug Policy"},{"key":"1041_CR6","doi-asserted-by":"crossref","unstructured":"Ellison M, Huton E, Webster L, Skolnick P. Reversal of opioid-induced respiratory depression in healthy volunteers comparison of intranasal nalmefene and intranasal naloxone. J Clinical Pharmacology. 2024;64(7):828\u201339.","DOI":"10.1002\/jcph.2421"},{"key":"1041_CR7","doi-asserted-by":"publisher","unstructured":"Choi S, Irwin MR, Kiyatkin EA. Xylazine effects on opioid-induced brain hypoxia; bioRxiv 2023; https:\/\/doi.org\/10.1101\/2023.03.31.535103","DOI":"10.1101\/2023.03.31.535103"},{"issue":"2","key":"1041_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13181-019-00756-5","volume":"16","author":"N Endo","year":"2020","unstructured":"Endo N, Ghaeli N, Duvallet C, et al. Rapid assessment of opioid exposure and treatment in cities through robotic collection and chemical analysis of wastewater. J Med Tox. 2020;16(2):195\u2013203.","journal-title":"J Med Tox"},{"key":"1041_CR9","unstructured":"NCHS National Vital Statistics System. Estimates for 2022 are based on provisional data. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Accessed 7 Oct 2024."}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-024-01041-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-024-01041-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-024-01041-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:05:22Z","timestamp":1736273122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-024-01041-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1007\/s13181-024-01041-w","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Leslie R. Dye, MD is a past president of ACMT, past Editor-in-Chief of <i>JMT<\/i>, Chair of the ACMT Addiction Toxicology Committee, and the <i>JMT<\/i> Addiction Medicine Section Editor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}